Search Results - "Lalor, Peggy A"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Plasmid DNA-Based Vaccines Protect Mice and Ferrets against Lethal Challenge with A/Vietnam/1203/04 (H5N1) Influenza Virus by Lalor, Peggy A., Webby, Richard J., Morrow, Jane, Rusalov, Denis, Kaslow, David C., Rolland, Alain, Smith, Larry R.

    Published in The Journal of infectious diseases (15-06-2008)
    “…Plasmid DNA (pDNA) vaccines represent an alternative to conventional inactivated influenza vaccines that are likely to experience supply constraints during a…”
    Get full text
    Journal Article
  2. 2

    IL-2 plasmid electroporation: from preclinical studies to phase I clinical trial by Horton, Holly M, Lalor, Peggy A, Rolland, Alain P

    “…Electroporation (EP)-assisted intralesional delivery of Interleukin-2 (IL-2) plasmid (pDNA) has the potential to increase the local concentration of the…”
    Get more information
    Journal Article
  3. 3

    Bone Mineralization and Spinal Fusion Evaluation of a Truss-based Interbody Fusion Device: Ovine Finite Element Analysis with Confirmatory In Vivo Outcomes by Kiapour, Ali, Seim, Howard B., Atkinson, Brent L., Lalor, Peggy A., Block, Jon E.

    Published in Spine (Philadelphia, Pa. 1976) (01-04-2022)
    “…Finite element analysis (FEA) and in vivo ovine spinal interbody fusion study. To determine comparative load-induced strain amplitudes, bone mineralization and…”
    Get full text
    Journal Article
  4. 4

    Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults by Keitel, Wendy A., Treanor, John J., El Sahly, Hana M., Evans, Thomas G., Kopper, Scott, Whitlow, Vanessa, Selinsky, Cheryl, Kaslow, David C., Rolland, Alain, Smith, Larry R., Lalor, Peggy A.

    Published in Human vaccines (01-08-2009)
    “…VCL-AB01, a cationic lipid-formulated plasmid DNA (pDNA)-based vaccine that contains genes encoding genetically detoxified B. anthracis protective antigen (PA)…”
    Get full text
    Journal Article
  5. 5

    Spontaneous Repair of Full-Thickness Defects of Articular Cartilage in a Goat Model : A Preliminary Study by Jackson, Douglas W, Lalor, Peggy A, Aberman, Harold M, Simon, Timothy M

    “…BackgroundFull-thickness defects measuring 3 mm in diameter have been commonly used in studies of rabbits to evaluate new procedures designed to improve the…”
    Get full text
    Journal Article
  6. 6

    Fortifying the Bone-Implant Interface Part 2: An In Vivo Evaluation of 3D-Printed and TPS-Coated Triangular Implants by MacBarb, Regina F, Lindsey, Derek P, Woods, Shane A, Lalor, Peggy A, Gundanna, Mukund I, Yerby, Scott A

    Published in International journal of spine surgery (01-01-2017)
    “…Minimally invasive surgical fusion of the sacroiliac (SI) joint using machined solid triangular titanium plasma spray (TPS) coated implants has demonstrated…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Bone Mineralization and Spinal Fusion Evaluation of a Truss-based Interbody Fusion Device: Ovine Finite Element Analysis with Confirmatory by Kiapour, Ali, Seim, Howard B., Atkinson, Brent L., Lalor, Peggy A., Block, Jon E.

    Published in Spine (Philadelphia, Pa. 1976) (28-09-2021)
    “…This ovine interbody fusion study compared load-induced strain amplitudes, bone mineralization, and fusion outcomes for different diameter struts in a…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67 by Lalor, P A, Mapp, P I, Hall, P A, Revell, P A

    Published in Rheumatology international (01-01-1987)
    “…The presence of proliferating cells has been sought in the synovium of rheumatoid arthritic (RA) and osteoarthritic (OA) joints using the monoclonal antibody…”
    Get full text
    Journal Article
  11. 11

    Comparison of Rabbit and Mouse Models for Persistence Analysis of Plasmid-Based Vaccines by Leamy, Vicky L., Martin, Terrie, Mahajan, Rohit, Vilalta, Adrian, Rusalov, Denis, Hartikka, Jukka, Bozoukova, Vesselina, Hall, Keith D., Morrow, Jane, Rolland, Alain P., Kaslow, David C., Lalor, Peggy A.

    Published in Human vaccines (01-05-2006)
    “…Experiments were conducted with a cationic lipid-formulated pDNA vaccine (VCL-AB01) to evaluate the models used to determine biodistribution, persistence and…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    The use of foetal calf serum as a blocking agent in double immunoenzyme-cytochemistry labelling with mouse monoclonal antibodies by Lalor, P A, Revell, P A

    Published in Journal of immunological methods (15-08-1989)
    “…Double immunoenzyme labelling has progressed in the past few years to double labelling using monoclonal antibodies (MAB) raised in the same species. It…”
    Get more information
    Journal Article
  15. 15

    Human alveolar macrophage suppression of lymphocyte proliferation. Accessory characteristics for the generation and functional expression of con A-induced suppressor cells by Ettensohn, D B, Lalor, P A, Roberts, Jr, N J

    Published in The American review of respiratory disease (01-04-1988)
    “…Human alveolar macrophages (AM) provide less accessory support for mitogen- and antigen-stimulated lymphocyte proliferation than do autologous blood-derived…”
    Get more information
    Journal Article